1Poon RT,lau CP,Cheung ST,et al. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma[J]. Cancer Res 2003,63 (12): 3121-3126.
2Poon RT,Ng IO,Lau C,et al. Serum vascular endothelial growth factor predicts venous invasion in hepatoellular carcinoma: a pro- spective study[J]. Ann Surg,2001,233(2) :227-235.
3Folkman J. Anti-angiogenesis in cancer therapy-endostatin and its mechanisms of action[J]. Expt Cell Res,2006,312:594-607.
4Lam VW, Ng KK, Chok KS, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma : analysis of risk factors and prognostic factors [J]. Ann Surg Oncol, 2008, 15 : 782 - 790.
5Matsui O, Kadoya M, Yoshikawa J, et al. Subsegmental transcatheter arterial embolization for stoat1 hepatocellular carcinomas: local therapeutic effect and 5-year survival rate [J]. Cancer Chemother Pharmacol, 1994, 33(Suppl) : $84- $88.
6Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J]. Ann Surg, 2006, 243:321 -328.
7Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin [J]. AJR, 2007, 188:480 - 488.
8Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)[J]. Eur Radiol, 2006, 16:661 - 669.
9Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treat-ment of malignant hepatic tumors at the threshold of a major break through[J]. Raidiographics, 2000, 20:9 - 27.
10Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liv- er tumors with percutaneous radio-frequency ablation : complications encountered in a muhicenter study [J]. Radiology, 2003, 226: 441- 451.
